Trials / Unknown
UnknownNCT05841147
Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban
Reduction of Microembolism After Stent-Assisted Coil Embolization of Unruptured Intracranial Aneurysms by Administration of Tirofiban：A Randomized, Controlled, Double-blind Trial
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Lu Hua · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to investigate whether intravenous injection of tilofiban can reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.The main questions it aims to answer are: * Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms？ * What dose of tirofiban is safe and effective?
Detailed description
We aim to reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tirofiban | Intravenous administration of tirofiban |
| DRUG | normal saline | Intravenous administration of normal saline |
Timeline
- Start date
- 2023-04-25
- Primary completion
- 2023-07-31
- Completion
- 2023-08-31
- First posted
- 2023-05-03
- Last updated
- 2023-05-03
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05841147. Inclusion in this directory is not an endorsement.